Total Payments
$9,793
2024 Payments
$812.79
Companies
30
Transactions
231
Medicare Patients
14,273
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$5,250 (53.6%)
Food & Beverage$4,543 (46.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250 | 4 | 53.6% |
| Food and Beverage | $4,543 | 227 | 46.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $5,767 | 30 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,008 | 54 | $0 (2024) |
| PFIZER INC. | $435.83 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $321.93 | 20 | $0 (2023) |
| Abbott Laboratories | $230.80 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $228.22 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $184.49 | 10 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $175.65 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $174.67 | 10 | $0 (2023) |
| CVRx, Inc. | $162.65 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $812.79 | 29 | CVRx, Inc. ($162.65) |
| 2023 | $708.56 | 36 | Novartis Pharmaceuticals Corporation ($165.82) |
| 2022 | $2,394 | 51 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($1,528) |
| 2021 | $4,065 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($3,850) |
| 2020 | $249.14 | 16 | Janssen Pharmaceuticals, Inc ($67.45) |
| 2019 | $550.00 | 25 | Novartis Pharmaceuticals Corporation ($196.69) |
| 2018 | $696.77 | 40 | Novartis Pharmaceuticals Corporation ($314.51) |
| 2017 | $316.49 | 16 | E.R. Squibb & Sons, L.L.C. ($111.39) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/04/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $162.65 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/24/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: Coronary | ||||||
| 10/24/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $12.03 | General |
| Category: Coronary | ||||||
| 10/09/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Heart Failure | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.23 | General |
| 09/10/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: VTE | ||||||
| 07/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Cardio-pulmonary | ||||||
| 06/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/11/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 06/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 04/17/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.03 | General |
| 04/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,538 | 8,205 | $969,464 | $257,847 |
| 2022 | 33 | 3,209 | 4,535 | $800,975 | $232,939 |
| 2021 | 34 | 3,615 | 5,661 | $978,710 | $286,180 |
| 2020 | 35 | 3,911 | 6,161 | $1.1M | $325,102 |
Total Patients
14,273
Total Services
24,562
Medicare Billing
$1.1M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 142 | 444 | $73,520 | $39,969 | 54.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 347 | 439 | $69,090 | $35,538 | 51.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 191 | 193 | $116,764 | $25,506 | 21.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 157 | 198 | $59,730 | $25,320 | 42.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 82 | 82 | $106,055 | $24,948 | 23.5% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 82 | 164 | $36,900 | $15,060 | 40.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 45 | 46 | $64,630 | $10,130 | 15.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 197 | 203 | $40,600 | $10,072 | 24.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 52 | 208 | $24,960 | $8,564 | 34.3% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 38 | 38 | $62,230 | $7,802 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $13,390 | $6,191 | 46.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 585 | 930 | $46,500 | $5,747 | 12.4% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $22,480 | $4,288 | 19.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 84 | 84 | $25,200 | $3,843 | 15.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 281 | 347 | $25,235 | $3,303 | 13.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $5,305 | $3,007 | 56.7% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 42 | 85 | $9,350 | $2,846 | 30.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 53 | 67 | $6,030 | $2,539 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 176 | 284 | $4,260 | $2,377 | 55.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 36 | $5,610 | $2,374 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 41 | $4,435 | $2,337 | 52.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 37 | 37 | $27,935 | $2,172 | 7.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 21 | $10,395 | $1,720 | 16.5% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 22 | 23 | $7,705 | $1,579 | 20.5% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 16 | 16 | $22,480 | $1,402 | 6.2% |
About Dr. Digant Bhatt, MD
Dr. Digant Bhatt, MD is a Cardiovascular Disease healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1902045495.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Digant Bhatt, MD has received a total of $9,793 in payments from pharmaceutical and medical device companies, with $812.79 received in 2024. These payments were reported across 231 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,250).
As a Medicare-enrolled provider, Bhatt has provided services to 14,273 Medicare beneficiaries, totaling 24,562 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Cartersville, GA
- Active Since 02/06/2009
- Last Updated 04/14/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1902045495
Products in Payments
- LifeVest (Device) $5,767
- ENTRESTO (Drug) $850.31
- ELIQUIS (Drug) $430.18
- XARELTO (Drug) $321.93
- Barostim Neo System (Device) $162.65
- FFRct (Device) $162.03
- LEQVIO (Drug) $157.94
- VYNDAQEL (Drug) $144.97
- UPTRAVI (Drug) $125.04
- Repatha (Biological) $109.26
- VERQUVO (Drug) $104.18
- Adempas (Drug) $103.44
- MITRACLIP (Device) $88.47
- Kerendia (Drug) $81.05
- Resolute (Device) $78.48
- Quadra Assura CRT Defibrillator (Device) $70.87
- BRILINTA (Drug) $62.38
- TYVASO (Drug) $54.85
- PRALUENT (Drug) $54.08
- WATCHMAN Access System (Device) $50.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cartersville
Maxwell Prempeh, Md, MD
Cardiovascular Disease — Payments: $65,029
Cardiovascular Disease $65,029
Ryan Chizner, Do, DO
Cardiovascular Disease — Payments: $9,242
Cardiovascular Disease $9,242
Rajeeve Subbiah, Md, MD
Cardiovascular Disease — Payments: $5,304
Cardiovascular Disease $5,304
Dr. Suresh Ramamurthy, Md, MD
Cardiovascular Disease — Payments: $5,248
Cardiovascular Disease $5,248
Godly Jack, Md, MD
Cardiovascular Disease — Payments: $2,439
Cardiovascular Disease $2,439
Ravinder Reddy, M.d, M.D
Cardiovascular Disease — Payments: $83.04
Cardiovascular Disease $83.04